| Previous studies with OGG1 germ line mutation analysis | | Author and year | Population | Cancer type | Sample size | Source of control | Techniques | Mutations | Cancer risk association | (Location and ethnicity) | Patients | Controls | |
| Arizono et al., 2008 [29] | Asian, Japanese | Bladder cancer | 251 | 251 | HB | PCR-RFLP | Ser326Cys | Associated | Bose et al., 2013 [30] | Asian, Indian | Liver cancer | 214 | 210 | HB | PCR-RFLP | Ser326Cys | Associated | Canbay et al., 2010 [31] | Caucasian, Turkish | Gastric cancer | 40 | 247 | HB/PB | PCR-RFLP | Ser326Cys | Associated | Canbay et al., 2011 [14] | Caucasian, Turkish | Colorectal cancer | 79 | 247 | HB | PCR-RFLP | Ser326Cys | Associated | Chang et al., 2009 [32] | Latino-African Americans | Lung cancer | 368 | 579 | HB | PCR-RFLP | Ser326Cys | Not associated | Chen et al., 2010 [33] | Asian, Chinese | Pterygium | 83 | 206 | HB | TaqMan assays | Ser326Cys | Not associated |
Chen et al., 2011 [34] | Asian, Chinese | Breast cancer | 518 | 777 | HB | HRM analysis | c.-18G>T, c.-23A>G, | Not associated | c.-53G>C, c.-45G>A, c.-63G>C | Cheng et al., 2012 [35] | Asian, Chinese | Lung cancer | 124 | 126 | HB | PCR-RFLP | Ser326Cys | Not associated | Cincin et al., 2012 [36] | Caucasian, Turkish | Endometrial cancer | 104 | 158 | HB/PB | PCR-RFLP | Ser326Cys | Associated | Dhillon et al., 2011 [37] | South Australian | Prostate cancer | 118 | 132 | HB | PCR-RFLP | Ser326Cys | Associated | Engin et al., 2010 [38] | Caucasian, Turkish | colorectal carcinoma | 110 | 116 | HB | PCR-RFLP | Ser326Cys | Not associated | Engin et al., 2011 [39] | Caucasian, Turkish | Gastric cancer | 106 | 116 | HB/PB | PCR-RFLP | Ser326Cys | Not associated | Farkasova et al., 2008 [40] | European | Cervical cancer | — | — | HB | PCR-RFLP | Ser326Cys | Not associated | Gangwar et al., 2009 [41] | Asian, North Indian | Urothelial bladder cancer | 212 | 250 | HB | PCR-RFLP | Ser326Cys | Associated | García-Quispes et al., 2011 [2] | European, Spanish | Thyroid cancer | 402 | 479 | HB/PB | iPLEX | Ser326Cys | Not associated | Jiao et al., 2007 [42] | Asian, Chinese | Gall bladder cancer | 204 | 209 | HB | PCR-RFLP | Ser326Cys | Associated | Karahalil et al., 2008 [43] | Caucasian, Turkish | Lung cancer | 165 | 250 | HB | PCR-RFLP | Ser326Cys | Not associated | Kim et al., 2013 [44] | Asian, Korean | Breast cancer | 346 | 361 | HB | SNP arrays | Ser326Cys | Associated | Kumar et al., 2011 [22] | Asian, Indian | Head and neck cancer | 278 | 278 | HB | PCR-RFLP | Ser326Cys | Associated | Laantri et al., 2011 [45] | North African | Nasopharyngeal cancer | 598 | 545 | HB | TaqMan assay | Ser326Cys | Not associated | Letkova et al., 2013 [46] | European | Lung cancer | 382 | 379 | HB | PCR-RFLP | Ser326Cys | Not associated | Li et al., 2011 [47] | Asian, Chinese | Lung cancer | 455 | 443 | HB | PCR-RFLP | Ser326Cys | Associated | Li et al., 2011 [48] | Asian, Chinese | Lymphoblastic leukemia | 415 | 511 | HB | TaqMan assay | Ser326Cys | Associated | Li et al., 2013 [49] | Asian, Chinese | Nasopharyngeal cancer | 231 | 300 | HB | PCR-RFLP | Ser326Cys | Not associated | Liu et al., 2010 [50] | Asian, Taiwan | Lung cancer | 358 | 716 | HB | PCR-RFLP | Ser326Cys | Associated | Luo et al., 2014 [17] | Asian, Chinese | Breast cancer | 194 | 245 | HB | PCR-CTPP | Ser326Cys | Not associated |
Mahjabeen et al., 2011 [19] | Asian, Pakistani | Head and neck Cancer | 300 | 300 | HB/PB | PCR-SSCP | Asp267Asn, Ser279Gly | Associated | Ile253Phe, Ala399Glu | Malik et al., 2010 [51] | Asian, Indian | Gastric Cancer | 108 | 195 | HB | PCR-RFLP | Ser326Cys | Not associated | Mandal et al., 2012 [52] | Asian, Indian | Prostate cancer | 192 | 224 | HB/PB | PCR-RFLP | Ser326Cys | Not associated |
Hsu et al., 2010 [53] | Asian, Chinese | Breast cancer | 401 | 533 | HB | PCR-RFLP | Ser326Cys | Associated | Mitra et al., 2011 [54] | Asian, Indian | Head and neck cancer | 350 | 225 | HB | PCR-RFLP | Ser326Cys | Associated | Mittal et al., 2012 [55] | Asian, Indian | Prostate cancer | 195 | 250 | PB | ARMS-PCR | Ser326Cys | Associated | Mittal et al., 2012 [55] | Asian, Indian | Bladder cancer | 212 | 250 | PB | ARMS-PCR | Ser326Cys | Associated | Narter et al., 2009 [56] | Caucasian, Turkish | Bladder cancer | 83 | 45 | HB | PCR-RFLP | Ser326Cys | Not associated | Ouyang et al., 2013 [57] | Asian, Chinese | lung adenocarcinoma | 82 | 201 | HB | PCR-RFLP | Ser326Cys | Not associated | Park et al., 2007 [58] | Asian, Korean | Colorectal cancer | 439 | 676 | HB | Sequencing | Ser326Cys | Not associated | Pawlowska et al., 2009 [59] | European, Polish | Laryngeal cancer | 253 | 253 | HB | PCR-RFLP | Ser326Cys | Associated | Przybylowska et al., 2013 [60] | Caucasian Polish | Colorectal cancer | 182 | 245 | HB/PB | PCR-RFLP | Ser326Cys | Associated | Ramaniuk et al., 2014 [61] | Russian, Belarus | Colorectal | 336 | 370 | HB | PCR-RFLP | Ser326Cys | Associated | Reeves et al., 2012 [62] | Australian/Polish | Colorectal cancer | 209 | 215 | HB | RT-PCR | Ser326Cys | Not associated | Romanowicz-Makowska et al., 2008 [63] | Caucasian, Polish | Breast cancer | 100 | 106 | HB | PCR-RFLP | Ser326Cys | Not associated | Romanowicz-Makowska et al., 2011 [64] | European, Polish | Endometrial cancer | 150 | 150 | HB | PCR-RFLP | Ser326Cys | Not associated |
de Ruyck et al., 2007 [65] | European, Belgian | Lung cancer | 110 | 110 | HB | PCR-RFLP | Ser326Cys | Negatively associated | Sameer et al., 2012 [66] | Asian, Indian | Colorectal cancer | 114 | 200 | HB | PCR-RFLP | Ser326Cys | Not associated | Sangrajrang et al., 2008 [67] | Asian, Thai | Breast cancer | 507 | 425 | HB | Melting curve analysis | Ser326Cys | Associated | Santonocito et al., 2012 [68] | European, Italian | Melanoma | 167 | 186 | HB | PCR-RFLP | Ser326Cys | Not associated | Santos et al., 2012 [69] | Caucasian | Thyroid cancer | 109 | 217 | HB | PCR-RFLP | Ser326Cys | Not associated |
Sliwinski et al., 2011 [70] | Caucasian Polish | Head and neck cancer | 265 | 280 | HB | PCR-RFLP | Ser326Cys | Associated | Sliwinski et al., 2009 [71] | Caucasian, Polish | Colorectal cancer | 100 | 100 | HB | PCR-RFLP | Ser326Cys | Associated | Sobczuk et al., 2012 [72] | Caucasian, Polish | Endometrial Cancer | 94 | 14 | HB | PCR-RFLP | Ser326Cys | Not associated | Srivastava et al., 2010 [73] | Asian, Indian | Gall bladder cancer | 230 | 230 | PB | PCR-RFLP | Ser326Cys | Associated | Srivastava et al., 2009 [74] | Asian, Indian | Gall bladder cancer | 173 | 204 | HB | PCR-RFLP | Ser326Cys | Associated | Stanczyk et al., 2011 [75] | Caucasian, Polish | Acute lymphoblastic leukemia | 97 | 131 | HB | PCR-RFLP | Ser326Cys | Associated | Sun et al., 2010 [76] | Asian, Chinese | Gastric cancer | 73 | 255 | HB | PCR-RFLP | Ser326Cys | Associated | Upadhyay et al., 2010 [77] | Asian, Indian | Esophageal cancer | 335 | 402 | HB | PCR-RFLP | Ser326Cys | Not associated | Wang et al., 2011 [78] | Asian, Taiwanese | Urothelial carcinoma | 460 | 540 | HB | PCR-RFLP | Ser326Cys | Associated | Xue et al., 2013 [79] | Asian, Chinese | Lung adenocarcinoma | 410 | 410 | HB | PCR-RFLP | Ser326Cys | Associated | Yang et al., 2008 [80] | Asian, Chinese | Laryngeal cancer | 72 | 72 | HB | PCR-RFLP | Ser326Cys | Associated | Yuan et al., 2012 [81] | Asian, Chinese | Hepatocellular cancer | 350 | 400 | HB | PCR-RFLP | Ser326Cys | Associated | Yun et al., 2012 [82] | Asian, Korean | Prostate cancer | 266 | 266 | HB | PCR-RFLP | Ser326Cys | Associated | Zhang et al., 2010 [83] | American | Prostate cancer | 193 | 197 | HB/PB | Mass spectrometry | Ser326Cys | Associated | Zhao et al., 2011 [84] | Asian, Chinese | Renal cell carcinoma | 572 | 574 | HB | TaqMan Assay | Ser326Cys | Associated |
|
|